The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy Subjects
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01693809|
Recruitment Status : Unknown
Verified September 2012 by Ana Maria Almeida de Sousa, Hospital do Servidor Publico Estadual.
Recruitment status was: Active, not recruiting
First Posted : September 26, 2012
Last Update Posted : October 2, 2012
The principal aim of this study is to evaluate the presence of changes in cervical vestibular evoked myogenic potentials (VEMPc) after acute intake of caffeine in healthy subjects.
Secondarily, it wants to standardize normal values exam VEMPc in otorhinolaryngology service of the hospital.
|Condition or disease||Intervention/treatment||Phase|
|Healthy Subjects||Drug: Caffeine||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||25 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy|
|Study Start Date :||January 2012|
|Estimated Primary Completion Date :||October 2012|
|Estimated Study Completion Date :||January 2013|
Caffeine 420mg, one time
- Alteration of p13 and n23 latency and p13-n23 amplitude before and after caffeine intake. [ Time Frame: 60 minutes ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01693809
|Hospital do Servidor Publico Estadual|
|São Paulo, Brazil|
|Study Chair:||Fabio Akira Suzuki, PhD||Hospital do Servidor Publico Estadual|
|Principal Investigator:||Ana Maria Almeida Sousa, MD||Hospital do Servidor Publico Estadual|